What does FirstPharma do?

FirstPharma is a commercial agency in Hove. Private Limited, started on 13 February 2015, 1 establishment.

What is the address of FirstPharma?

The registered office of FirstPharma is located at Boechoutsesteenweg 17, 2540 Hove.

Is FirstPharma still active?

Yes. According to the CBE (29 October 2026) FirstPharma is active, legal situation “Normale toestand”, started on 13 February 2015.

Is FirstPharma registered on Peppol?

Yes, FirstPharma is registered on the Peppol network with ID 0208:0597961547.

What is the enterprise number of FirstPharma?

The enterprise number of FirstPharma is BE0597961547.

When was FirstPharma founded?

FirstPharma was founded on 13 February 2015.

Who are the directors of FirstPharma?

According to the 2025 annual accounts, the directors of FirstPharma are: Alegria Comm. V., Déjà Vu Comm. V., Levante Comm V., Salento Comm. V..

Is FirstPharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 February 2015; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did FirstPharma make in 2025?

FirstPharma posted a profit after taxes of € 8,450 in financial year 2025.

What is the revenue of FirstPharma?

As a small company, FirstPharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 15,500.

FirstPharma (Private Limited) - Hove - BE0597961547

Dossier FirstPharma, printed on 29 October 2026 from databakkes.be/en/0597961547/firstpharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

FirstPharma from Hove, company number BE0597961547, closed financial year 2025 with a result of € 8,450 after tax. For that financial year FirstPharma recorded a gross margin of € 15,500 and equity of € 48,217. Compared with financial year 2024, the result moved from € -5,822 to € 8,450. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.

What it is worth Growing

€ 48,217

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,450

▲ still € 5,822 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 85,130

▲ 123% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 41,367.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 73,835

▼ 53% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 956

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,815 Gross margin 2022: € 105,815 First fiscal year in the series	€ 95,749 Gross margin 2023: € 95,749 ▼ 10% vs 2022 (€ 105,815) Unfavourable step	€ 161 Gross margin 2024: € 161 ▼ € 95,588 vs 2023 (€ 95,749) Unfavourable step	€ 15,500 Gross margin 2025: € 15,500 ▲ € 15,339 vs 2024 (€ 161) Favourable step	▲ € 15,339
Profit after taxes	€ 97,217 Profit after taxes 2022: € 97,217 First fiscal year in the series	€ 81,200 Profit after taxes 2023: € 81,200 ▼ 16% vs 2022 (€ 97,217) Unfavourable step	€ -5,822 Profit after taxes 2024: € -5,822 ▼ € 87,022 vs 2023 (€ 81,200) Unfavourable step	€ 8,450 Profit after taxes 2025: € 8,450 ▲ € 14,272 vs 2024 (€ -5,822) Favourable step	▲ € 14,272
Equity	€ -35,610 Equity 2022: € -35,610 First fiscal year in the series	€ 45,590 Equity 2023: € 45,590 ▲ € 81,200 vs 2022 (€ -35,610) Favourable step	€ 39,767 Equity 2024: € 39,767 ▼ 13% vs 2023 (€ 45,590) Unfavourable step	€ 48,217 Equity 2025: € 48,217 ▲ 21% vs 2024 (€ 39,767) Favourable step	▲ 21%
Total debts	€ 509,043 Total debts 2022: € 509,043 First fiscal year in the series	€ 230,039 Total debts 2023: € 230,039 ▼ 55% vs 2022 (€ 509,043) Favourable step	€ 165,473 Total debts 2024: € 165,473 ▼ 28% vs 2023 (€ 230,039) Favourable step	€ 76,175 Total debts 2025: € 76,175 ▼ 54% vs 2024 (€ 165,473) Favourable step	▼ 54%
Cash	€ 110,496 Cash 2022: € 110,496 First fiscal year in the series	€ 23,611 Cash 2023: € 23,611 ▼ 79% vs 2022 (€ 110,496) Unfavourable step	€ 38,216 Cash 2024: € 38,216 ▲ 62% vs 2023 (€ 23,611) Favourable step	€ 85,130 Cash 2025: € 85,130 ▲ 123% vs 2024 (€ 38,216) Favourable step	▲ 123%
Retained profit	€ -42,460 Retained profit 2022: € -42,460 First fiscal year in the series	€ 38,740 Retained profit 2023: € 38,740 ▲ € 81,200 vs 2022 (€ -42,460) Favourable step	€ 32,917 Retained profit 2024: € 32,917 ▼ 15% vs 2023 (€ 38,740) Unfavourable step	€ 41,367 Retained profit 2025: € 41,367 ▲ 26% vs 2024 (€ 32,917) Favourable step	▲ 26%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 8,452 Bank debt 2024: € 8,452 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 8,452) Favourable step	▼ 100%
Balance sheet total	€ 473,433 Balance sheet total 2022: € 473,433 First fiscal year in the series	€ 275,629 Balance sheet total 2023: € 275,629 ▼ 42% vs 2022 (€ 473,433) Unchanged	€ 205,240 Balance sheet total 2024: € 205,240 ▼ 26% vs 2023 (€ 275,629) Unchanged	€ 124,392 Balance sheet total 2025: € 124,392 ▼ 39% vs 2024 (€ 205,240) Unchanged	▼ 39%

Key figures of FirstPharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FirstPharma?

What happened at FirstPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 23, 2026 New annual accounts for financial year 2025: profit of € 8,450. filed late Source: NBB ↗
Feb 13, 2015 New establishment in Hove. KBO
Feb 13, 2015 Start of the company according to the CBE. KBO
2015 Alegria Comm. V. became a director. NBB
2015 Déjà Vu Comm. V. became a director. NBB
2015 Levante Comm V. became a director. NBB
2015 Salento Comm. V. became a director. NBB

In short

From € 97,217 profit in 2022 to € 8,450 profit in 2025.

Paid € 10,212 in corporate taxes since 2022.

Best year ever: 2022, with € 97,217 profit.

Original PDFs at the National Bank ↗

Management

Alegria Comm. V. Déjà Vu Comm. V. Levante Comm V. Salento Comm. V.

PENELOPE-ANTWERPEN

Apotheek Antverpia

BRONKHORST

FirstPharma

Behind FirstPharma are Alegria Comm. V., Déjà Vu Comm. V., Levante Comm V. and Salento Comm. V.. The same people are also behind PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO and ANTWERPS DISTRIBUTIE CENTRUM.

Directors

According to the 2025 annual accounts

Alegria Comm. V.

Director · represented by Geert Van Genechten

Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, VITAFARMA

since 2015

Déjà Vu Comm. V.

Director · represented by Koen Van Genechten

Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, VITAFARMA

since 2015

Levante Comm V.

Director · represented by Hilde Van Genechten

Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, VITAFARMA

since 2015

Salento Comm. V.

Director · represented by Katleen Van Genechten

Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, VITAFARMA

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Boechoutsesteenweg 17

2540 Hove

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0597.961.547

VAT number

BE 0597.961.547

Registered office

Boechoutsesteenweg 17, 2540 Hove

Names & denominations

FirstPharma

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 February 2015

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Handelsbemiddeling in de groothandel in voedings- en genotmiddelen

Overige niet-gespecialiseerde detailhandel

Overige detailhandel in voedingsmiddelen, neg

Detailhandel in cosmetica en toiletartikelen

Detailhandel via postorderbedrijven of via internet

Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

FirstPharma

Financials

What happened to FirstPharma?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions